Reviva Pharmaceuticals Holdings, Inc.RVPHNASDAQ
Loading
Year-over-year net income growth rate
5Y CAGR
-13.7%/yr
Long-term compound
Percentile
P83
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2024 | 23.79% |
| 2023 | -61.31% |
| 2022 | -185.61% |
| 2021 | -125.24% |
| 2020 | -346.77% |
| 2019 | 49.60% |
| 2018 | 0.00% |